These
more established medication items have a place with recent Ranbaxy Laboratories
Ltd. furthermore, are not being advertised in the US since 2008.
Sun
Pharmaceutical Industries Ltd has educated BSE that one of the Company's
entirely possessed backups has intentionally asked for the USFDA to pull back
endorsement for 28 Abbreviated New Drug Applications (ANDAs). These more
seasoned medication items have a place with recent Ranbaxy Laboratories Ltd.
what's more, are not being showcased in the US since 2008.
Stock
Commentary:
Sun
Pharmaceuticals Industries Ltd is as of now exchanging at Rs 632.1, around Rs
0.1 or 0.02% from its past shutting of Rs 632.2 on the BSE.
The
scrip opened at Rs 633 and has touched a high and low of Rs 638 and Rs 630
separately. So far 936542(NSE+BSE) shares were exchanged on the counter. The
present market top of the organization is Rs 152156.01 crore.
The
BSE bunch "A" supply of face esteem Rs 1 has touched a 52 week high
of Rs 898 on 23-Feb-2016 and a 52 week low of Rs 572.4 on 09-Nov-2016. Most recent
one week high and low of the scrip remained at Rs 693 and Rs 630.55 separately.
The
promoters holding in the organization remained at 54.97 % while Institutions
and Non-Institutions held 33.34 % and 11.68 % separately.
The
stock is right now exchanging underneath its 200 DMA.
Author : Wealth Research
No comments:
Post a Comment